For customized anticancer treatment for pets, we conduct organoid-based anticancer drug susceptibility testing
Through PODO Therapeutics’ organoid-based anticancer drug pre-screening test, you can maximize the effectiveness of anticancer treatment for your pet with an “individualized approach” that reflects the characteristics of each patient
For the first time in Korea, an organoid-based anticancer drug susceptibility evaluation method for human patients with proven clinical effectiveness has been applied to companion animal diagnosis
Polaris PET
Clicking on the picture below will take you to the PDST service platform homepage
